Oncolytic Viruses for Cancer Immunotherapy

Simple item page
dc.contributor.authorAhmed, Ashraqat
dc.date.accessioned2022-08-21T10:37:33Z
dc.date.available2022-08-21T10:37:33Z
dc.date.issued2022-08-16
dc.description.abstractIn preclinical and clinical research, oncolytic virotherapy has yielded promise but limited results. Induction of tumor-specific immunity is an important therapeutic mechanism of oncolytic virotherapy, in addition to direct oncolytic activity. As a result, the insertion of immune stimulator genes and sensible combinatorial therapy with other immunotherapies can boost the efficacy of oncolytic viruses.en_US
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/3933
dc.publisherLibyan International Medical University Faculty of AMSen_US
dc.titleOncolytic Viruses for Cancer Immunotherapyen_US
dc.title.alternativeOncolytic Viruses for Cancer Immunotherapyen_US
dc.typeOtheren_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Oncolytic Viruses for Cancer Immunotherapy.pdf
Size:
737.84 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Student Guide